ONC Latest Headlines

Early Data Milestone: BeOne Medicines Advances BGB-15025 in Immune Oncology

at www.tipranks.com (Fri, 26-Jun 12:31 PM)

BeOne Medicines Insiders Quietly Unload Major Stakes in High-Profile Stock Move

at www.tipranks.com (Thu, 25-Jun 10:01 PM)

BeOne Medicines’ Real-World Lung Cancer Study Puts Tislelizumab Under the Market Microscope

at www.tipranks.com (Thu, 25-Jun 12:31 PM)

ONC's Phase 3 HERIZON-GEA Study Shows Seven-Month Survival Gain in HER2+ Gastroesophageal Cancer

Market Chameleon (Thu, 28-May 7:08 AM)

BeOne Medicines Showcases Over 60 Abstracts at ASCO and EHA 2026, Cementing Leadership in CLL and Expanding its Solid Tumor Pipeline

Market Chameleon (Thu, 21-May 7:10 AM)